Micrognos Advisory
de-risking Opportunity
What
Micrognos is a scientific advisory service for biotechs and investors assessing market potential of gastrointestinal therapeutics projects. We have special focus on gut microbes of relevance to disease conditions within and beyond the gut.
Our range of expertise is fully translational spanning microbiology, biochemistry and clinical practice with relevance for discovery, targeting and delivery phases of diagnostics and therapeutics pipelines. This affords incisive analysis of emerging mechanisms of disease and technologies that promise to tackle them.
Micrognos offers analysis to hone project pitch with insights informed by real world, clinical, market conditions and identified needs.
Guided by a broad experiential range spanning molecular biochemistry, microbial-host interactions, and bedside clinico-pathophysiology.
An increasing range of disease conditions from inflammatory bowel disease to non-alcoholic steatohepatitis and colorectal cancer are associated with gut pathobionts.
The age of whole genome sequencing has ushered novel insights into potential virulence pathways in even previously known pathogens.
Our service engagement is flexible to suit your target objective and timeline.
Expert Opinion
Most suitable for analysis and opinion of a specific topic on ad hoc basis.
Advisory
Ideal for longer term engagement on product development runway from pre clinical market discovery to launch.
Strategic Advise
Suited for market potential analysis and strategic advise especially at earlier funding stage. Focused, iterative analysis of risk-reward optimization.